TrialBlood advances2019

Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation.

Andrea S Henden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.